ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/Research Reagent/Fmoc-N-methyl-L-alloisoleucine
C22H25NO4
367.4 g/mol
Research Reagent

Fmoc-N-methyl-L-alloisoleucine

CAS1821797-58-3
Category
Research Reagent
Compound Class
Peptide
Primary Use
Research Compound

Fmoc-N-methyl-L-alloisoleucine is a research reagent utilized in peptide synthesis. It serves as a protected amino acid derivative for incorporating N-methylated alloisoleucine residues into peptides.

research compound for peptide synthesis

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Fmoc-N-methyl-L-alloisoleucine?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.80

Fmoc-N-methyl-L-valine

CAS84000-11-3

pharmaceutical intermediate

ApplicationSame Use

(S)-N-Fmoc-4-Bromophenylalanine

CAS198561-04-5

research compound

ApplicationSame Use

4-Methylphenyl-L-alanine

CAS1991-87-3

research compound

ApplicationSame Use

FMOC-L-LYS[C20-OTBU-GLU(OTBU)-AEEA-AEEA]-OH

CAS2460751-66-8

research compound

ApplicationSame Use

(S)-N-Fmoc-3-(2-naphthyl)alanine

CAS112883-43-9

research compound

ReferenceSame Category

(trimethylsilyl)methyllithium

CAS1822-00-0

research compound

ReferenceSame Category

2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol

CAS182230-43-9

research compound

ReferenceSame Category

Benzylone

CAS1823274-68-5

research compound

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(2S,3R)-2-[9H-fluoren-9-ylmethoxycarbonyl(methyl)amino]-3-methylpentanoic acid

InChIKey

IQIOLCJHRZWOLS-VLIAUNLRSA-N

SMILES

CC[C@@H](C)[C@@H](C(=O)O)N(C)C(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13

Synonyms (4)
  • Fmoc-N-Me-Allo-Ile-OH

Sourcing Fmoc-N-methyl-L-alloisoleucine?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→